An open-label prospective study of the real-life use of onabotulinumtoxinA for the treatment of chronic migraine: The REPOSE study

1. Ahmed, F.
2. Gaul, C.
3. Garciá-Moncó, J.C.
4. Sommer, K.
5. Martelletti, P.

Export

Export

×

MLA

modern-language-association

APA

apa

Chicago

chicago-fullnote-bibliography

Harvard

harvard-cite-them-right

Vancouver

vancouver-author-date

---

RIS BibTex

Export

×

This document cannot be exported because it belongs to another portal.

Full text

lock_openFull text externo

DOI: 10.1186/S10194-019-0976-1 GOOGLE SCHOLAR lock_openOpen access editor

Data source: Scopus